Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2025-12-24 @ 5:33 PM
NCT ID:
NCT01266668
Eligibility Criteria:
Inclusion Criteria:
* Stage I or II of primary breast DLBCL treated with R-CHOP
* Stage I or II of nodal DLBCL treated with R-CHOP
Definition of primary breast DLBCL - Isolated breast involvement with or without nodal disease, which include distant nodal disease as well as regional nodal disease
Definition of nodal DLBCL
\- The disease was only limited to the lymph nodes or lymphoid organs
Exclusion Criteria:
* Primary breast DLBCL or nodal DLBCL treated without rituximab
* Secondary breast DLBCL
* Recurrent DLBCL
* Stage III or IV of nodal DLBCL with extranodal involvement as a dissemination process
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
85 Years
Study:
NCT01266668
Study Brief:
Protocol Section:
NCT01266668